Twelve artifacts of evidence and fiction, made to be walked through in one night.
Artifice NYC is a curatorial research nonprofit working between creative science and new media fictions.
We produce immersive, site-specific showcases and open creative infrastructure — a public archive practitioners build and control — shaping how speculative practice and emerging technology define the way we live.
A 501(c)(3) founded in 2024. Chapter 005, Sights: Science Fiction, drew 998 people in one night. Everything enters the Artifact Index, a free public record of how the work gets made.
Artifice studies the technology already arriving through the futures we imagine for it. Chapter 006 turns that on the climate question — the evidence on one side, the futures it implies on the other. Science fiction has always decided who the future belongs to; this hands the decision to the people the genre usually writes out.
Existing works brought to their final form for one exhibition — clear headliners next to emerging artists, six per format.
A fashion show grown from biomaterials, performance wired into hardware, and installation built at the scale of a flagship storefront. Made to be walked through.
Performance and film. Bodies, sound, and image on a clock — the future as it lands on you in the dark, once.
Lineup is target / in conversation — all existing works, confirmed at artist lock.
| Item | Budget |
| Artist honoraria — 2 headliners ($5K ea) · 2 BLACKBOX ($1K) · 8 others ($500) | 16,000 |
| XR / immersive development + spatial AV | 19,000 |
| Production — materials · lighting · sound · staging | 12,500 |
| Labor — Producer · Woo · TD · 5 PAs · Security | 13,200 |
| Venue (Hero target — in-kind via Rhizome / ZeroSpace $3K) | 0–3,000 |
| Documentation + methodology paper | 7,000 |
| Audience — catering · accessibility · signage | 6,000 |
| Marketing + compliance | 5,000 |
| Contingency (10%) | ~8,000 |
| Total | ~89,800 |
Gates: venue lock · artist lock · production lock · scope freeze. Date and venue TBD — target venue Hero, co-presented with Rhizome.